| PDF (519kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-48467
- DOI to cite this document:
- 10.5283/epub.4846
Alternative links to fulltext:Pubmed
Abstract
The enantiomeric [1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes were synthesized and tested on the hormone-sensitive human MCF7 breast cancer cell line and on the P388 leukemia of the mouse. They showed a strong and comparable activity on both tumor models.
Owner only: item control page